Optimising sampling regimes and data collection to inform surveillance for trachoma control.
It is estimated that 190 million individuals are at risk of blindness from trachoma, and that control by mass drug administration (MDA) is reducing this risk in many populations.Programs are monitored using prevalence of follicular trachoma disease (TF) in children.However, as programs progress to low prevalence there are challenges interpreting th